These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Hyperpigmentation with daunorubicin therapy. Kelly TM; Fishman LM; Lessner HE Arch Dermatol; 1984 Feb; 120(2):262-3. PubMed ID: 6696484 [No Abstract] [Full Text] [Related]
26. Persistent post-sclerotherapy pigmentation due to minocycline. Three cases and a review of post-sclerotherapy pigmentation. Green D J Cosmet Dermatol; 2002 Dec; 1(4):173-82. PubMed ID: 17147536 [TBL] [Abstract][Full Text] [Related]
27. Images in cardiovascular medicine. The blue man: amiodarone-induced skin discoloration. Enseleit F; Wyss CA; Duru F; Noll G; Ruschitzka F Circulation; 2006 Feb; 113(5):e63. PubMed ID: 16461825 [No Abstract] [Full Text] [Related]
28. Loss of skin pigment caused by imatinib therapy. McPartlin S; Leach M Br J Haematol; 2005 May; 129(4):448. PubMed ID: 15877727 [No Abstract] [Full Text] [Related]
29. [Purple hand syndrome and intravenous phenytoine]. Schmutz J; Barbaud A; Tréchot P Ann Dermatol Venereol; 2000 May; 127(5):548. PubMed ID: 10863194 [No Abstract] [Full Text] [Related]
30. [Skin pigmentation induced by minocycline]. Verret JL; Avenel M; Simard C; Solier MA; Barbin B Ann Dermatol Venereol; 1983; 110(9):777-8. PubMed ID: 6660789 [No Abstract] [Full Text] [Related]
31. [An epidemiologic examination on the prevalence of the periodontal diseases and oral pigmentation in Yusho patients in 1996]. Hashiguchi I; Anan H; Maeda K; Akamine A; Fukuyama H; Okumura H Fukuoka Igaku Zasshi; 1997 May; 88(5):226-30. PubMed ID: 9194347 [TBL] [Abstract][Full Text] [Related]
32. [Chloasma, a complication of treatments with synthetic progestational hormones (7 cases)]. Thiers H; Villedieu P; Moulin G J Med Lyon; 1966 Dec; 47(111):1815-6 passim. PubMed ID: 5990283 [No Abstract] [Full Text] [Related]
33. Nail discoloration occurring after 8 weeks of minocycline therapy. Ban M; Kitajima Y J Dermatol; 2007 Oct; 34(10):699-701. PubMed ID: 17908141 [TBL] [Abstract][Full Text] [Related]
34. [Nail hyperpigmentation as a secondary effect of doxorubicin]. Sanz Ortiz J; Méndez Batán MA; Fariñas Alvarez C; Gutiérrez del Río C Med Clin (Barc); 1982 Jun; 79(1):49-50. PubMed ID: 7121110 [No Abstract] [Full Text] [Related]
35. A study of cases of leucomelanodermatosis due to phenyl-phenol compounds. Ito K; Nishitani K; Hara I Bull Pharm Res Inst; 1968 Sep; 76():5-13. PubMed ID: 5757261 [No Abstract] [Full Text] [Related]
36. [An epidemiologic examination on the prevalence of the periodontal diseases and oral pigmentation in Yusho patients in 1998]. Hashiguchi I; Furukawa K; Akamine A; Fukuyama H; Okumura H Fukuoka Igaku Zasshi; 1999 May; 90(5):150-3. PubMed ID: 10396869 [TBL] [Abstract][Full Text] [Related]
37. The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population. Roberts G; Capell HA J Rheumatol; 2006 Jul; 33(7):1254-7. PubMed ID: 16758512 [TBL] [Abstract][Full Text] [Related]
38. [Sequential changes of oral pigmentations of patients with yusho]. Akamine A; Hashiguchi I; Kishi T; Furukawa T; Aono M Fukuoka Igaku Zasshi; 1983 May; 74(5):284-8. PubMed ID: 6411573 [No Abstract] [Full Text] [Related]
39. Chlorpromazine-induced cutaneous pigmentation--effect of replacement with clozapine. Lal S; Lal S J Psychiatry Neurosci; 2000 May; 25(3):281. PubMed ID: 10863889 [No Abstract] [Full Text] [Related]
40. Amiodarone-induced cutaneous and corneal pigment deposits. Onofrey BE; Jones WL; Magnus DE J Am Optom Assoc; 1984 May; 55(5):337-9. PubMed ID: 6725829 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]